GH1 and neoplasm: Initially, considering the high levels of GH and that, besides surgery, adjuvant therapy would probably be necessary in order to reduce the tumor, pharmacological treatment with octreotide 30 mg (a somatostatin analogue that inhibits GH and IGF-1) was administered every 28 days.